Evidence map›Paper›PMID 35759054›Full record

ArticleEJNMMI research2022

Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson's disease.

Takuro Shiiba, Kazuki Takano, Akihiro Takaki, Shugo Suwazono

Abstract read
In one paragraph

Article in EJNMMI research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Detection of parkinson's disease with neuroimaging modalities using machine learning and artificial intelligence: a systematic review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Pooled it
  2. Pooled it
  3. Quantitative evaluation ofScientific reports · 2024
    Article
  4. Article
  5. Review
  6. Radiomics insight into the neurodegenerative "Frontiers in nuclear medicine · 2023
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Takuro ShiibaDepartment of Molecular Imaging, School of Medical Sciences, Fujita Health University, 1-98, Dengakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan. takuro.shiiba@fujita-hu.ac.jp.ORCID http://orcid.org/0000-0001-5515-091X
Kazuki TakanoDepartment of Molecular Imaging, School of Medical Sciences, Fujita Health University, 1-98, Dengakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Akihiro TakakiDepartment of Radiological Technology, Faculty of Fukuoka Medical Technology, Teikyo University, 6-22 Misakimachi, Omuta-shi, Fukuoka, 836-8505, Japan.
Shugo SuwazonoDepartment of Neurology and Center for Clinical Neuroscience, National Hospital Organization Okinawa National Hospital, 3-20-14 Ganeko, Ginowan, 901-2214, Okinawa, Japan.

Funding

Japan Society for the Promotion of Science London 18K15565Japan Society for the Promotion of Science London 21K15791
6 · The paper itself

Abstract

backgroundWe hypothesised that the radiomics signature, which includes texture information of dopamine transporter single-photon emission computed tomography (DAT-SPECT) images for Parkinson's disease (PD), may assist semi-quantitative indices. Herein, we constructed a radiomics signature using DAT-SPECT-derived radiomics features that effectively discriminated PD from healthy individuals and evaluated its classification performance.

resultsWe analysed 413 cases of both normal control (NC, n = 101) and PD (n = 312) groups from the Parkinson's Progression Markers Initiative database. Data were divided into the training and two test datasets with different SPECT manufacturers. DAT-SPECT images were spatially normalised to the Montreal Neurologic Institute space. We calculated 930 radiomics features, including intensity- and texture-based features in the caudate, putamen, and pallidum volumes of interest. The striatum uptake ratios (SURs) of the caudate, putamen, and pallidum were also calculated as conventional semi-quantification indices. The least absolute shrinkage and selection operator was used for feature selection and construction of the radiomics signature. The four classification models were constructed using a radiomics signature and/or semi-quantitative indicator. Furthermore, we compared the classification performance of the semi-quantitative indicator alone and the combination with the radiomics signature for the classification models. The receiver operating characteristics (ROC) analysis was used to evaluate the classification performance. The classification performance of SUR

conclusionWe constructed a DAT-SPECT image-derived radiomics signature. Performance analysis showed that the current radiomics signature would be helpful for the diagnosis of PD and has the potential to provide robust diagnostic performance.

Indexed as

Dopamine transporterParkinson’s diseaseRadiomicsRadiomics signatureSPECTTexture

Identifiers

PMID35759054
PMCPMC9237203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.